Bio-Techne (TECH) Profit After Tax (2009 - 2026)
Bio-Techne's (TECH) quarterly Profit After Tax came in at $51.0 million in Q1 2026, up 94.94% year-on-year from $26.2 million in Q1 2025, and up 27.43% quarter-over-quarter from $40.1 million in Q4 2025.
Bio-Techne (TECH) Profit After Tax (2009 - 2026) Analysis & Trends
Bio-Techne's Profit After Tax history runs 18 years deep, the most recent figure standing at $51.0 million for Q1 2026.
- On a quarterly basis, Profit After Tax rose 94.94% year-over-year to $51.0 million in Q1 2026; TTM through Mar 2026 was $110.8 million, a 13.74% increase from a year earlier, with the FY2025 full-year figure at $73.4 million, down 52.9% from the prior year.
- Profit After Tax rose to $51.0 million in Q1 2026 per TECH's latest filing, from $40.1 million in the prior quarter.
- Across five years, Profit After Tax topped out at $89.7 million in Q3 2022 and bottomed at -$219.1 million in Q2 2022.
- The 5-year median for Profit After Tax is $41.8 million (2023), against an average of $28.1 million.
- Across the five-year window, Profit After Tax tumbled 1102.75% in 2022 and surged 329.51% in 2025, its largest moves.
- Year by year, Profit After Tax stood at $50.0 million in 2022, then slipped by 16.37% to $41.8 million in 2023, then plunged by 77.7% to $9.3 million in 2024, then soared by 329.51% to $40.1 million in 2025, then advanced by 27.43% to $51.0 million in 2026.
- Per Business Quant, the three latest TECH Profit After Tax figures stand at $51.0 million (Q1 2026), $40.1 million (Q4 2025), and $33.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Bio-Techne | 11.19 Bn | 10.98 Bn | 208.29 Mn | 51.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.05 Mn |
| Dec 31, 2025 | 40.06 Mn |
| Sep 30, 2025 | 33.67 Mn |
| Jun 30, 2025 | -13.94 Mn |
| Mar 31, 2025 | 26.19 Mn |
| Dec 31, 2024 | 9.33 Mn |
| Sep 30, 2024 | 33.60 Mn |
| Jun 30, 2024 | 28.34 Mn |
| Mar 31, 2024 | 49.06 Mn |
| Dec 31, 2023 | 41.82 Mn |
| Sep 30, 2023 | 50.99 Mn |
| Jun 30, 2023 | 75.48 Mn |
| Mar 31, 2023 | 70.22 Mn |
| Dec 31, 2022 | 50.01 Mn |
| Sep 30, 2022 | 89.73 Mn |
| Jun 30, 2022 | -219.09 Mn |
| Mar 31, 2022 | 60.74 Mn |
| Dec 31, 2021 | 72.06 Mn |
| Sep 30, 2021 | 68.98 Mn |
| Jun 30, 2021 | -18.22 Mn |